ICLRNasdaqServices-Commercial Physical & Biological Research
ICON PLC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on May 27, 2026
$168.14−2.04 (-1.20%)
Close on Oct 19, 2026
- Market cap
- $13.01B
- P/E (TTM)
- 300.2
- Dividend yield
- –
Ownership
Who owns ICON's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 37 sales
Net sold $4.04M
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Artisan Partners Holdings LP | 8,361,303 | 10.90% | 13G (passive) amendment | Feb 27, 2026 |
| Artisan Investments GP LLC | 7,184,870 | 9.00% | 13G (passive) amendment | Jun 30, 2025 |
| Wellington Group Holdings LLP | 5,913,037 | 7.70% | 13G (passive) amendment | Mar 31, 2026 |
| FMR LLC | 5,271,321 | 6.90% | 13G (passive) amendment | Jun 30, 2026 |
| Invesco Ltd. | 5,264,236 | 6.90% | 13G (passive) amendment | Jun 30, 2026 |
| Harris Associates, Inc. | 4,351,317 | 5.70% | 13G (passive) | Mar 31, 2026 |
| Artisan Partners Asset Management Inc. | 4,290,924 | 5.30% | 13G (passive) | Mar 31, 2025 |
| Orbis Investment Management Ltd | 4,208,000 | 5.50% | 13G (passive) amendment | Dec 31, 2025 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Barry Edward Balfe | Chief Executive Officer, Director | 4,804 | 0.01% | Aug 11, 2026 |
| Nigel Bernard John Clerkin | Chief Financial Officer | 7,652 | 0.01% | Aug 12, 2026 |
| Emer Lyons | Chief Accounting Officer | 752 | 0.00% | Aug 12, 2026 |
| John Dr Climax | Director | 293,553 | 0.38% | Sep 18, 2026 |
| Eugene Pacelli McCague | Director | 3,811 | 0.00% | Sep 18, 2026 |
| Ronan Martin Murphy | Director | 8,852 | 0.01% | Sep 18, 2026 |
| Linda Grais | Director | 6,819 | 0.01% | Aug 12, 2026 |
| Ciaran Murray | Director | 22,849 | 0.03% | Aug 12, 2026 |
| Kevin Francis Egan | Director | – | – | Aug 12, 2026 |
| Anne Clem Whitaker | Director | 958 | 0.00% | Aug 12, 2026 |
| Julie O'Neill | Director | 3,588 | 0.00% | Aug 12, 2026 |
| Jeffrey Thomas Elliott | Director | – | – | Aug 11, 2026 |
| Stephen A. Cutler | Director | 79,278 | 0.10% | Mar 18, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Ronan Martin Murphy Director | Sep 17, 2026 | Option exercise | +5,005 | $125.74 | $629.33K | 8,852 |
| Ronan Martin Murphy Director | Sep 17, 2026 | Sale | −5,005 | $175.00 | $875.88K | 3,847 |
| Eugene Pacelli McCague Director | Sep 17, 2026 | Sale | −3,255 | $175.00 | $569.63K | 3,811 |
| Eugene Pacelli McCague Director | Sep 17, 2026 | Option exercise | +3,255 | $125.74 | $409.28K | 7,066 |
| John Dr Climax Director | Sep 16, 2026 | Option exercise | +5,005 | $125.74 | $629.33K | 7,092 |
| John Dr Climax Director | Sep 16, 2026 | Sale | −5,005 | $175.00 | $875.88K | 2,087 |
| Ciaran Murray Director | Aug 11, 2026 | Sale | −280 | $162.72 | $45.56K | 22,849 |
| Ciaran Murray Director | Aug 11, 2026 | Sale | −305 | $163.77 | $49.95K | 22,544 |
| Ciaran Murray Director | Aug 11, 2026 | Sale | −212 | $165.51 | $35.09K | 20,452 |
| Ciaran Murray Director | Aug 11, 2026 | Sale | −1,880 | $164.47 | $309.20K | 20,664 |
| Julie O'Neill Director | Aug 11, 2026 | Sale | −642 | $164.47 | $105.59K | 3,588 |
| Julie O'Neill Director | Aug 11, 2026 | Sale | −105 | $163.77 | $17.20K | 4,230 |
| Julie O'Neill Director | Aug 11, 2026 | Sale | −95 | $162.72 | $15.46K | 4,335 |
| Julie O'Neill Director | Aug 11, 2026 | Sale | −73 | $165.51 | $12.08K | 3,515 |
| John Dr Climax Director | Aug 11, 2026 | Sale | −67 | $165.51 | $11.09K | 2,087 |
| John Dr Climax Director | Aug 11, 2026 | Sale | −591 | $164.47 | $97.20K | 2,154 |
| John Dr Climax Director | Aug 11, 2026 | Sale | −88 | $162.72 | $14.32K | 2,840 |
| John Dr Climax Director | Aug 11, 2026 | Sale | −95 | $163.77 | $15.56K | 2,745 |
| Ronan Martin Murphy Director | Aug 11, 2026 | Sale | −88 | $162.72 | $14.32K | 4,600 |
| Ronan Martin Murphy Director | Aug 11, 2026 | Sale | −96 | $163.77 | $15.72K | 4,504 |
| Ronan Martin Murphy Director | Aug 11, 2026 | Sale | −590 | $164.47 | $97.04K | 3,914 |
| Ronan Martin Murphy Director | Aug 11, 2026 | Sale | −67 | $165.51 | $11.09K | 3,847 |
| Eugene Pacelli McCague Director | Aug 11, 2026 | Sale | −67 | $165.51 | $11.09K | 3,811 |
| Eugene Pacelli McCague Director | Aug 11, 2026 | Sale | −590 | $164.47 | $97.04K | 3,878 |
| Eugene Pacelli McCague Director | Aug 11, 2026 | Sale | −96 | $163.77 | $15.72K | 4,468 |
| Eugene Pacelli McCague Director | Aug 11, 2026 | Sale | −88 | $162.72 | $14.32K | 4,564 |
| Linda Grais Director | Aug 11, 2026 | Sale | −97 | $163.77 | $15.89K | 6,819 |
| Linda Grais Director | Aug 11, 2026 | Sale | −67 | $165.51 | $11.09K | 6,162 |
| Linda Grais Director | Aug 11, 2026 | Sale | −590 | $164.47 | $97.04K | 6,229 |
| Linda Grais Director | Aug 11, 2026 | Sale | −87 | $162.72 | $14.16K | 6,916 |
| Nigel Bernard John Clerkin Chief Financial Officer | Aug 11, 2026 | Sale | −259 | $163.77 | $42.42K | 7,652 |
| Nigel Bernard John Clerkin Chief Financial Officer | Aug 11, 2026 | Sale | −237 | $162.72 | $38.56K | 7,911 |
| Nigel Bernard John Clerkin Chief Financial Officer | Aug 11, 2026 | Sale | −1,591 | $164.47 | $261.67K | 6,061 |
| Nigel Bernard John Clerkin Chief Financial Officer | Aug 11, 2026 | Sale | −180 | $165.51 | $29.79K | 5,881 |
| Anne Clem Whitaker Director | Aug 11, 2026 | Sale | −590 | $164.47 | $97.04K | 958 |
| Anne Clem Whitaker Director | Aug 11, 2026 | Sale | −67 | $165.51 | $11.09K | 891 |
| Anne Clem Whitaker Director | Aug 11, 2026 | Sale | −96 | $163.77 | $15.72K | 1,548 |
| Anne Clem Whitaker Director | Aug 11, 2026 | Sale | −88 | $162.72 | $14.32K | 1,644 |
| Ciaran Murray Director | Aug 10, 2026 | Option exercise | +2,677 | – | – | 23,129 |
| Julie O'Neill Director | Aug 10, 2026 | Option exercise | +1,732 | – | – | 4,430 |
| John Dr Climax Director | Aug 10, 2026 | Option exercise | +1,732 | – | – | 2,928 |
| Ronan Martin Murphy Director | Aug 10, 2026 | Option exercise | +1,732 | – | – | 4,688 |
| Eugene Pacelli McCague Director | Aug 10, 2026 | Option exercise | +1,732 | – | – | 4,652 |
| Linda Grais Director | Aug 10, 2026 | Option exercise | +1,732 | – | – | 7,003 |
| Nigel Bernard John Clerkin Chief Financial Officer | Aug 10, 2026 | Option exercise | +918 | – | – | 4,773 |
| Nigel Bernard John Clerkin Chief Financial Officer | Aug 10, 2026 | Option exercise | +3,375 | – | – | 8,148 |
| Anne Clem Whitaker Director | Aug 10, 2026 | Option exercise | +1,732 | – | – | 1,732 |
| Barry Edward Balfe Chief Executive Officer, Director | Aug 10, 2026 | Sale | −78 | $165.14 | $12.88K | 4,804 |
| Barry Edward Balfe Chief Executive Officer, Director | Aug 10, 2026 | Sale | −304 | $163.80 | $49.80K | 4,882 |
| Barry Edward Balfe Chief Executive Officer, Director | Aug 7, 2026 | Option exercise | +728 | – | – | 5,186 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Martin Murphy Ronan Director | Sep 17, 2026 | 5,005 | $875.88K | Sep 17, 2026 | Exercise of Options Under a Registered Plan |
| Pacelli McCague Eugene Director | Sep 17, 2026 | 3,255 | $569.63K | Sep 17, 2026 | Exercise of Options Under a Registered Plan |
| Climax John Director | Sep 16, 2026 | 5,005 | $875.88K | Sep 16, 2026 | Exercise of Options Under a Registered Plan |
| Whitaker Anne Director | Aug 11, 2026 | 841 | $138.17K | Aug 11, 2026 | Restricted Stock Vesting Under a Registered Plan |
| Sue Grais Linda Director | Aug 11, 2026 | 841 | $138.17K | Aug 11, 2026 | Restricted Stock Vesting Under a Registered Plan |
| Pacelli McCague Eugene Director | Aug 11, 2026 | 841 | $138.17K | Aug 11, 2026 | Restricted Stock Vesting Under a Registered Plan |
| Climax John Director | Aug 11, 2026 | 841 | $138.17K | Aug 11, 2026 | Restricted Stock Vesting Under a Registered Plan |
| Martin Murphy Ronan Director | Aug 11, 2026 | 841 | $138.17K | Aug 11, 2026 | Restricted Stock Vesting Under a Registered Plan |
| Ann O'Neill Julie Director | Aug 11, 2026 | 915 | $150.33K | Aug 11, 2026 | Restricted Stock Vesting Under a Registered Plan |
| Clerkin Nigel Officer | Aug 11, 2026 | 2,267 | $372.45K | Aug 11, 2026 | Restricted Stock Vesting Under a Registered Plan |
| Murray Ciaran Director | Aug 11, 2026 | 2,677 | $439.81K | Aug 11, 2026 | Restricted Stock Vesting Under a Registered Plan |
| Edward Balfe Barry Officer | Aug 10, 2026 | 382 | $62.68K | Aug 10, 2026 | Restricted Stock Vesting Under a Registered Plan |
| Edward Balfe Barry Officer | Mar 9, 2026 | 2,862 | $300.88K | Mar 9, 2026 | Restricted Stock Units Vested under Issuer S-8 Registered Plan |
| Edward Balfe Barry Officer | Mar 4, 2026 | 566 | $61.84K | Mar 4, 2026 | Restricted stock vesting under a registered plan |
| Clerkin Nigel Officer | Nov 3, 2025 | 1,473 | $249.29K | Nov 3, 2025 | Restricted stock vesting under a registered plan |